nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.47	0.564	CbGaD
Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.363	0.436	CbGaD
Trifluoperazine—CALM1—autonomic nervous system—Gilles de la Tourette syndrome	0.0063	0.0874	CbGeAlD
Trifluoperazine—CALY—midbrain—Gilles de la Tourette syndrome	0.00392	0.0543	CbGeAlD
Trifluoperazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00384	0.0532	CbGeAlD
Trifluoperazine—EBPL—nervous system—Gilles de la Tourette syndrome	0.00352	0.0488	CbGeAlD
Trifluoperazine—EBPL—central nervous system—Gilles de la Tourette syndrome	0.00339	0.047	CbGeAlD
Trifluoperazine—S100A4—midbrain—Gilles de la Tourette syndrome	0.00338	0.0469	CbGeAlD
Trifluoperazine—CALY—nervous system—Gilles de la Tourette syndrome	0.00322	0.0447	CbGeAlD
Trifluoperazine—CALY—central nervous system—Gilles de la Tourette syndrome	0.0031	0.043	CbGeAlD
Trifluoperazine—EBPL—brain—Gilles de la Tourette syndrome	0.00269	0.0373	CbGeAlD
Trifluoperazine—CALY—brain—Gilles de la Tourette syndrome	0.00246	0.0341	CbGeAlD
Trifluoperazine—S100A4—brain—Gilles de la Tourette syndrome	0.00213	0.0295	CbGeAlD
Trifluoperazine—HTR6—nervous system—Gilles de la Tourette syndrome	0.00168	0.0232	CbGeAlD
Trifluoperazine—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00161	0.0224	CbGeAlD
Trifluoperazine—HTR6—brain—Gilles de la Tourette syndrome	0.00128	0.0178	CbGeAlD
Trifluoperazine—CALM3—midbrain—Gilles de la Tourette syndrome	0.00124	0.0172	CbGeAlD
Trifluoperazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00118	0.0163	CbGeAlD
Trifluoperazine—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.00111	0.0154	CbGeAlD
Trifluoperazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.001	0.0139	CbGeAlD
Trifluoperazine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000991	0.0137	CbGeAlD
Trifluoperazine—CALM2—midbrain—Gilles de la Tourette syndrome	0.000974	0.0135	CbGeAlD
Trifluoperazine—CALM1—midbrain—Gilles de la Tourette syndrome	0.00097	0.0134	CbGeAlD
Trifluoperazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000968	0.0134	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000967	0.0134	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000932	0.0129	CbGeAlD
Trifluoperazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000896	0.0124	CbGeAlD
Trifluoperazine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000815	0.0113	CbGeAlD
Trifluoperazine—CALM2—nervous system—Gilles de la Tourette syndrome	0.000801	0.0111	CbGeAlD
Trifluoperazine—CALM1—nervous system—Gilles de la Tourette syndrome	0.000797	0.0111	CbGeAlD
Trifluoperazine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000785	0.0109	CbGeAlD
Trifluoperazine—CALM3—brain—Gilles de la Tourette syndrome	0.000779	0.0108	CbGeAlD
Trifluoperazine—CALM2—central nervous system—Gilles de la Tourette syndrome	0.000771	0.0107	CbGeAlD
Trifluoperazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000768	0.0106	CbGeAlD
Trifluoperazine—CALM1—central nervous system—Gilles de la Tourette syndrome	0.000767	0.0106	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000751	0.0104	CbGeAlD
Trifluoperazine—HTR2C—brain—Gilles de la Tourette syndrome	0.00074	0.0103	CbGeAlD
Trifluoperazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000736	0.0102	CbGeAlD
Trifluoperazine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000723	0.01	CbGeAlD
Trifluoperazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000709	0.00983	CbGeAlD
Trifluoperazine—SIGMAR1—brain—Gilles de la Tourette syndrome	0.000697	0.00966	CbGeAlD
Trifluoperazine—HTR1A—brain—Gilles de la Tourette syndrome	0.000623	0.00863	CbGeAlD
Trifluoperazine—CALM2—brain—Gilles de la Tourette syndrome	0.000612	0.00849	CbGeAlD
Trifluoperazine—CALM1—brain—Gilles de la Tourette syndrome	0.000609	0.00845	CbGeAlD
Trifluoperazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000591	0.00819	CbGeAlD
Trifluoperazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000581	0.00806	CbGeAlD
Trifluoperazine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000574	0.00796	CbGeAlD
Trifluoperazine—DRD2—brain—Gilles de la Tourette syndrome	0.000563	0.0078	CbGeAlD
Trifluoperazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.00056	0.00776	CbGeAlD
Trifluoperazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000486	0.00673	CbGeAlD
Trifluoperazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000468	0.00648	CbGeAlD
Trifluoperazine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000463	0.00549	CbGpPWpGaD
Trifluoperazine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000462	0.00548	CbGpPWpGaD
Trifluoperazine—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000459	0.00544	CbGpPWpGaD
Trifluoperazine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000456	0.00542	CbGpPWpGaD
Trifluoperazine—HRH1—brain—Gilles de la Tourette syndrome	0.000444	0.00616	CbGeAlD
Trifluoperazine—EBP—Metabolism—HDC—Gilles de la Tourette syndrome	0.000416	0.00494	CbGpPWpGaD
Trifluoperazine—Flupentixol—DRD2—Gilles de la Tourette syndrome	0.000404	0.0378	CrCbGaD
Trifluoperazine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000403	0.00478	CbGpPWpGaD
Trifluoperazine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000395	0.00469	CbGpPWpGaD
Trifluoperazine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000389	0.00462	CbGpPWpGaD
Trifluoperazine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000388	0.0046	CbGpPWpGaD
Trifluoperazine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000387	0.00537	CbGeAlD
Trifluoperazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000371	0.00515	CbGeAlD
Trifluoperazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000358	0.0336	CrCbGaD
Trifluoperazine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000331	0.00392	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000325	0.00385	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000321	0.00381	CbGpPWpGaD
Trifluoperazine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000318	0.00441	CbGeAlD
Trifluoperazine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000315	0.00374	CbGpPWpGaD
Trifluoperazine—Flupentixol—HTR2A—Gilles de la Tourette syndrome	0.000312	0.0292	CrCbGaD
Trifluoperazine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000306	0.00425	CbGeAlD
Trifluoperazine—Nefazodone—SLC6A3—Gilles de la Tourette syndrome	0.000303	0.0284	CrCbGaD
Trifluoperazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000279	0.0261	CrCbGaD
Trifluoperazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000273	0.0255	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.00027	0.0253	CrCbGaD
Trifluoperazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000245	0.0229	CrCbGaD
Trifluoperazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000244	0.0229	CrCbGaD
Trifluoperazine—ABCB1—brain—Gilles de la Tourette syndrome	0.000243	0.00337	CbGeAlD
Trifluoperazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000233	0.0218	CrCbGaD
Trifluoperazine—Zuclopenthixol—DRD2—Gilles de la Tourette syndrome	0.000227	0.0213	CrCbGaD
Trifluoperazine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.000225	0.0211	CrCbGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000225	0.00267	CbGpPWpGaD
Trifluoperazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.00022	0.0206	CrCbGaD
Trifluoperazine—Quetiapine—DRD4—Gilles de la Tourette syndrome	0.00022	0.0206	CrCbGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000218	0.00259	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000215	0.00255	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—HDC—Gilles de la Tourette syndrome	0.000215	0.00255	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000206	0.00244	CbGpPWpGaD
Trifluoperazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000203	0.0191	CrCbGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000203	0.00241	CbGpPWpGaD
Trifluoperazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000202	0.0189	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000201	0.0188	CrCbGaD
Trifluoperazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000199	0.0186	CrCbGaD
Trifluoperazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000196	0.0183	CrCbGaD
Trifluoperazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000196	0.0183	CrCbGaD
Trifluoperazine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.000194	0.0182	CrCbGaD
Trifluoperazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000193	0.0181	CrCbGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000192	0.00228	CbGpPWpGaD
Trifluoperazine—Quetiapine—DRD3—Gilles de la Tourette syndrome	0.000189	0.0177	CrCbGaD
Trifluoperazine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.000189	0.0177	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000187	0.0175	CrCbGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000187	0.00222	CbGpPWpGaD
Trifluoperazine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.000181	0.0169	CrCbGaD
Trifluoperazine—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000179	0.00213	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000178	0.00212	CbGpPWpGaD
Trifluoperazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000178	0.0167	CrCbGaD
Trifluoperazine—Zuclopenthixol—HTR2A—Gilles de la Tourette syndrome	0.000175	0.0164	CrCbGaD
Trifluoperazine—Nefazodone—HTR2A—Gilles de la Tourette syndrome	0.000174	0.0163	CrCbGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000174	0.00207	CbGpPWpGaD
Trifluoperazine—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000174	0.00206	CbGpPWpGaD
Trifluoperazine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000173	0.00205	CbGpPWpGaD
Trifluoperazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000169	0.0158	CrCbGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000166	0.00197	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000165	0.00196	CbGpPWpGaD
Trifluoperazine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.000163	0.0153	CrCbGaD
Trifluoperazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000163	0.0152	CrCbGaD
Trifluoperazine—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000162	0.00192	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000161	0.00192	CbGpPWpGaD
Trifluoperazine—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.000161	0.0151	CrCbGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000161	0.00191	CbGpPWpGaD
Trifluoperazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000157	0.00187	CbGpPWpGaD
Trifluoperazine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000157	0.00187	CbGpPWpGaD
Trifluoperazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0147	CrCbGaD
Trifluoperazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000154	0.0144	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000153	0.0144	CrCbGaD
Trifluoperazine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000153	0.00181	CbGpPWpGaD
Trifluoperazine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000152	0.0018	CbGpPWpGaD
Trifluoperazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000151	0.0142	CrCbGaD
Trifluoperazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000151	0.0142	CrCbGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00015	0.00178	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00015	0.00178	CbGpPWpGaD
Trifluoperazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000149	0.014	CrCbGaD
Trifluoperazine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000148	0.00175	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000147	0.00174	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000146	0.00173	CbGpPWpGaD
Trifluoperazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000146	0.0136	CrCbGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000144	0.0017	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000143	0.0017	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000142	0.00169	CbGpPWpGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000142	0.00169	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000142	0.00169	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000142	0.00168	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000142	0.00168	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000141	0.00167	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000141	0.00167	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000139	0.00165	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000139	0.00165	CbGpPWpGaD
Trifluoperazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000139	0.013	CrCbGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000138	0.00164	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000138	0.00163	CbGpPWpGaD
Trifluoperazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000137	0.00163	CbGpPWpGaD
Trifluoperazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000137	0.0128	CrCbGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000137	0.00162	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000137	0.00162	CbGpPWpGaD
Trifluoperazine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000136	0.00161	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000135	0.0016	CbGpPWpGaD
Trifluoperazine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.000134	0.0126	CrCbGaD
Trifluoperazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000134	0.0125	CrCbGaD
Trifluoperazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000134	0.00159	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000133	0.00157	CbGpPWpGaD
Trifluoperazine—Quetiapine—DRD2—Gilles de la Tourette syndrome	0.000131	0.0123	CrCbGaD
Trifluoperazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000131	0.0122	CrCbGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00013	0.00154	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00013	0.00154	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00013	0.00154	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00013	0.00154	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000129	0.00153	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000128	0.00152	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000128	0.00151	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000127	0.00151	CbGpPWpGaD
Trifluoperazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0118	CrCbGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000125	0.00148	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000123	0.00146	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000123	0.00146	CbGpPWpGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00145	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000121	0.00144	CbGpPWpGaD
Trifluoperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000121	0.00144	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000121	0.00143	CbGpPWpGaD
Trifluoperazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000121	0.0113	CrCbGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00012	0.00143	CbGpPWpGaD
Trifluoperazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000119	0.0112	CrCbGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000119	0.00142	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000119	0.00141	CbGpPWpGaD
Trifluoperazine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000117	0.00139	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000117	0.00139	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000117	0.00139	CbGpPWpGaD
Trifluoperazine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000115	0.00137	CbGpPWpGaD
Trifluoperazine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.000113	0.0106	CrCbGaD
Trifluoperazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000113	0.0105	CrCbGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000111	0.00132	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000111	0.00132	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000109	0.0013	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000109	0.00129	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000108	0.00129	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000108	0.00128	CbGpPWpGaD
Trifluoperazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000107	0.0101	CrCbGaD
Trifluoperazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000106	0.00994	CrCbGaD
Trifluoperazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00992	CrCbGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00125	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000105	0.00125	CbGpPWpGaD
Trifluoperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00125	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000105	0.00124	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000105	0.00124	CbGpPWpGaD
Trifluoperazine—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.000104	0.00972	CrCbGaD
Trifluoperazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00968	CrCbGaD
Trifluoperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00122	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000103	0.00122	CbGpPWpGaD
Trifluoperazine—Quetiapine—HTR2A—Gilles de la Tourette syndrome	0.000101	0.00949	CrCbGaD
Trifluoperazine—CALM2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	9.97e-05	0.00118	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	9.97e-05	0.00118	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.81e-05	0.00116	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.76e-05	0.00116	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.52e-05	0.00113	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.37e-05	0.00111	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.35e-05	0.00111	CbGpPWpGaD
Trifluoperazine—Promazine—HTR2A—Gilles de la Tourette syndrome	9.31e-05	0.00872	CrCbGaD
Trifluoperazine—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.28e-05	0.0011	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.25e-05	0.0011	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.24e-05	0.0011	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.2e-05	0.00109	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.17e-05	0.00109	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.1e-05	0.00108	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.08e-05	0.00108	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.08e-05	0.00108	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.02e-05	0.00107	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.93e-05	0.00106	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.93e-05	0.00106	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.91e-05	0.00106	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.91e-05	0.00106	CbGpPWpGaD
Trifluoperazine—Clozapine—HTR2A—Gilles de la Tourette syndrome	8.71e-05	0.00816	CrCbGaD
Trifluoperazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.47e-05	0.00101	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.46e-05	0.001	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.32e-05	0.000987	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.3e-05	0.000985	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.28e-05	0.000983	CbGpPWpGaD
Trifluoperazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	8.19e-05	0.00768	CrCbGaD
Trifluoperazine—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.04e-05	0.000954	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.92e-05	0.00094	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.78e-05	0.000923	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.65e-05	0.000908	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.63e-05	0.000906	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.52e-05	0.000892	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.49e-05	0.000889	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—HDC—Gilles de la Tourette syndrome	7.46e-05	0.000885	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.3e-05	0.000866	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—HDC—Gilles de la Tourette syndrome	7.21e-05	0.000856	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—HDC—Gilles de la Tourette syndrome	7.21e-05	0.000856	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.87e-05	0.000815	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.83e-05	0.000811	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.8e-05	0.000807	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.13e-05	0.000727	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.1e-05	0.000724	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.03e-05	0.000716	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.95e-05	0.000706	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.92e-05	0.000703	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.92e-05	0.000703	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000692	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.81e-05	0.00069	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	5.65e-05	0.000671	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.57e-05	0.000661	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.54e-05	0.000658	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.54e-05	0.000657	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.51e-05	0.000654	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.4e-05	0.000641	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.38e-05	0.000639	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.38e-05	0.000638	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.3e-05	0.000628	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.28e-05	0.000627	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.24e-05	0.000622	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.22e-05	0.00062	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.2e-05	0.000617	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.18e-05	0.000615	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.14e-05	0.00061	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.13e-05	0.000609	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.05e-05	0.000599	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.03e-05	0.000597	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.03e-05	0.000597	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.01e-05	0.000594	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.89e-05	0.00058	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.81e-05	0.000571	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.8e-05	0.000569	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.79e-05	0.000568	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.78e-05	0.000567	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.76e-05	0.000565	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.74e-05	0.000563	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.72e-05	0.00056	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.71e-05	0.000559	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.7e-05	0.000558	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.69e-05	0.000556	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.67e-05	0.000554	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.66e-05	0.000553	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.58e-05	0.000544	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.57e-05	0.000542	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.51e-05	0.000535	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.44e-05	0.000527	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.35e-05	0.000516	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.34e-05	0.000515	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.31e-05	0.000512	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.27e-05	0.000507	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.26e-05	0.000505	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.2e-05	0.000498	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.02e-05	0.000477	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.99e-05	0.000474	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.000461	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.88e-05	0.00046	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.86e-05	0.000458	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.86e-05	0.000458	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.86e-05	0.000458	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.75e-05	0.000445	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.75e-05	0.000445	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.61e-05	0.000428	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.53e-05	0.000418	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.51e-05	0.000416	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.49e-05	0.000414	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.49e-05	0.000414	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.41e-05	0.000405	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.35e-05	0.000397	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.29e-05	0.000391	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.29e-05	0.00039	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.28e-05	0.00039	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.27e-05	0.000388	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.19e-05	0.000379	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.18e-05	0.000377	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000367	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.04e-05	0.000361	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000355	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.98e-05	0.000354	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.97e-05	0.000353	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.96e-05	0.000351	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.89e-05	0.000343	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.84e-05	0.000337	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.83e-05	0.000336	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000334	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000333	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000331	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.78e-05	0.00033	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.76e-05	0.000327	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.75e-05	0.000327	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000321	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.7e-05	0.00032	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.57e-05	0.000305	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.56e-05	0.000304	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.0003	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000299	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000299	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.00029	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.45e-05	0.00029	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.00028	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.29e-05	0.000272	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.28e-05	0.000271	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.28e-05	0.000271	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.21e-05	0.000263	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.21e-05	0.000263	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000253	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.08e-05	0.000247	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000246	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000245	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000245	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000217	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.8e-05	0.000213	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.00021	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.000209	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000177	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.44e-05	0.000171	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.44e-05	0.000171	CbGpPWpGaD
